Key Points: • Executive Team Appointed • Focus on revenue...

Key Points: • Executive Team Appointed • Focus on revenue growth, international cannabis market The Hydroponics Company Limited (“THC” or “the Company”) is pleased to provide the following update to set out the THC Board’s direction over the coming months. THC’s Australian medicinal cannabis business has secured operating licences and established valuable international partnerships and supply of product, supported by a solid revenue-generating business in Canada. Your Board has an experienced team that has a clear record of delivery with skills and expertise to accelerate the pace of revenue growth, particularly in Canada where the hydroponics operations have now been cleared to pursue new country-wide agencies. All have been with THC since listing on the ASX. Chairman, Steven Xu commented “As one of its earliest investors and now Chairman, I have seen the rapid growth of THC to its current status, positioning itself as an international contender in the global cannabis marketplace”. An executive search firm has been appointed to recommend an Independent Chairman as well as seeking candidates both domestically and internationally that will bring further cannabis industry experience to THC for growing a world class cannabis company. Steven Xu will continue to act as Chairman of THC, pending this appointment. Additions to the Executive Team • Ken Charteris, Dr Andrew Beehag, and Henry Kinstlinger. • Ken Charteris has been appointed Executive Director of Canndeo. • Henry Kinstlinger has been appointed Joint Company Secretary of THC